Swertiamarin Ameliorates HFD+DMN-Induced Hepatic Steatosis and Fibrosis Markers via Downregulation of ASK1/MAPK Signaling Pathway
Background: Nonalcoholic fatty liver disease (NAFLD) and liver fibrosis are major health concerns globally, especially in patients with type 2 diabetes mellitus (T2DM). Dysregulated insulin signaling and chronic inflammation are central to disease progression. Objective: This study evaluates the hepatoprotective and an...